Antibacterial activity and mechanism of optimized THPA conjugated dipeptides against methicillin-resistant...

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Multidrug-resistant bacterial infections, particularly Methicillin-resistant Staphylococcus aureus (MRSA), pose a significant global health threat.
• Conventional antibiotics are increasingly ineffective against these resistant strains.
• Short cationic antimicrobial peptides offer a potential alternative due to their high efficacy and low cytotoxicity.

Purpose of the Study:

• To synthesize, characterize, and evaluate novel tetrahydropiperic acid (THPA) conjugate αβ-hybrid peptides for antibacterial activity.
• To assess the safety and efficacy of these peptides against MRSA.
• To explore potential synergistic effects with existing antibiotics and elucidate the mechanism of action.

Main Methods:

• Synthesis and characterization of three THPA-conjugated αβ-hybrid peptides (P1, P2, P3).
• Antibacterial evaluation against MRSA, including determination of bactericidal potency and safety index (hemolytic activity).
• Combinatorial studies with vancomycin and mechanistic investigations (e.g., membrane disruption assays).

Main Results:

• Peptide P3 demonstrated superior bactericidal potency against MRSA compared to P1 and P2.
• Peptide P3 exhibited a favorable safety profile with low hemolytic activity and the best safety index.
• A synergistic antibacterial effect was observed when peptide P3 was combined with vancomycin.
• Mechanistic studies indicated that peptide P3 disrupts the bacterial membrane of MRSA.

Conclusions:

• The synthesized THPA-conjugated αβ-hybrid peptide P3 shows significant potential as a therapeutic agent against MRSA infections.
• Peptide P3's efficacy, safety, and synergistic activity suggest it could be a valuable addition to the antimicrobial arsenal.
• Further development of peptide P3 could help combat the growing challenge of multidrug-resistant bacterial infections.